Suryeun Chung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Suryeun Chung has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Dong Seop Jeong
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications - Kiick Sung
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
2 shared publications - Yang Hyun Cho
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications - Darae Kim
Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea
1 shared publication - Eun-Seok Jeon
Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea
1 shared publication - Hye Ree Kim
Department of Internal Medicine, Gyeongsang National University Hospital, School of Medicine, Gyeongsang National University, Jinju 52727, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 25 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 963
Impact of Previous Thoracotomy on Outcomes of Open Thoracoabdominal Aortic Aneurysm Repair: A Retrospective Propensity Score-Matched Analysis
Objectives: Open repair remains widely used for TAAA (Thoracoabdominal Aortic Aneurysm), but disease progression may require reoperation via repeat thoracotomy, which is technically challenging. These procedures involve increased risks due to adhesions and altered anatomy. This study aims to evaluate the impact of repeat thoracotomy on early surgical outcomes in TAAA patients. Methods: We conducted a retrospective cohort study of 214 patients who underwent open TAAA repair between June 1996 and March 2023. Among them, 30 underwent repeat thoracotomy (RT), and 184 underwent their first thoracotomy (FT). To reduce baseline discrepancies, propensity score matching (3:1) was performed, resulting in 22 RT patients matched with 45 FT patients. The primary outcome was 30-day mortality, while secondary outcomes included postoperative complications. Results: In the matched cohort, the median operative time was longer in the RT group (500 min, IQR [476.0–552.0]) compared to the FT group (459.0 min, IQR [426.5–514.0]; p = 0.037). Thirty-day mortality was similar between groups (RT: 4.5%, FT: 2.2%, p = 0.433). No cases of paraplegia occurred. Postoperative bleeding was observed more frequently in the RT group (RT: 13.6% vs. FT: 2.2%, p = 0.050), suggesting a potential difference, but statistical significance was not reached. Other major complications showed no significant differences. Conclusions: In this propensity score matched analysis, repeat thoracotomy was not associated with statistically significant differences in early outcomes following open TAAA repair. These findings should be interpreted cautiously and suggest that prior left thoracotomy may not be associated with worse early outcomes in experienced centers.
- 25 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 963
Open AccessImpact of Previous Thoracotomy on Outcomes of Open Thoracoabdominal Aortic Aneurysm Repair: A Retrospective Propensity Score-Matched Analysis
Objectives: Open repair remains widely used for TAAA (Thoracoabdominal Aortic Aneurysm), but disease progression may require reoperation via repeat thoracotomy, which is technically challenging. These procedures involve increased risks due to adhesions and altered anatomy. This study aims to evaluate the impact of repeat thoracotomy on early surgical outcomes in TAAA patients. Methods: We conducted a retrospective cohort study of 214 patients who underwent open TAAA repair between June 1996 and March 2023. Among them, 30 underwent repeat thoracotomy (RT), and 184 underwent their first thoracotomy (FT). To reduce baseline discrepancies, propensity score matching (3:1) was performed, resulting in 22 RT patients matched with 45 FT patients. The primary outcome was 30-day mortality, while secondary outcomes included postoperative complications. Results: In the matched cohort, the median operative time was longer in the RT group (500 min, IQR [476.0–552.0]) compared to the FT group (459.0 min, IQR [426.5–514.0]; p = 0.037). Thirty-day mortality was similar between groups (RT: 4.5%, FT: 2.2%, p = 0.433). No cases of paraplegia occurred. Postoperative bleeding was observed more frequently in the RT group (RT: 13.6% vs. FT: 2.2%, p = 0.050), suggesting a potential difference, but statistical significance was not reached. Other major complications showed no significant differences. Conclusions: In this propensity score matched analysis, repeat thoracotomy was not associated with statistically significant differences in early outcomes following open TAAA repair. These findings should be interpreted cautiously and suggest that prior left thoracotomy may not be associated with worse early outcomes in experienced centers.
- Open Access
- 16 May 2022
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 9 (5) , 160
Thoracoscopic Implantation of Epicardial Left Ventricular Lead for Cardiac Resynchronization Therapy
(1) Background: Limited data exist on the safety and efficacy of epicardial left ventricular (LV) lead placement using video-assisted thoracoscopic surgery (VATS) for cardiac resynchronization therapy (CRT). (2) Methods: Acute and post-discharge outcomes of CRT were compared between patients with epicardial LV leads (Epicardial-LV group, n = 13) and those with endocardial LV leads (Endocardial-LV group, n = 243). (3) Results: Epicardial LV leads were implanted via VATS alone (n = 8) or along with mini-thoracotomy (n = 5), for failed endocardial implantation (n = 11) or recurrent lead dislodgement (n = 2). All epicardial procedures under general anesthesia with one-lung ventilation were successfully completed in 1.0 ± 0.4 h without phrenic nerve stimulation. LV pacing thresholds in the epicardial-LV (1.5 ± 1.0 V) and endocardial-LV (1.3 ± 0.8 V) were comparable (p = 0.651). All patients were discharged alive post-VATS 8.8 ± 3.9 days. During the follow-up (34.3 ± 28.6 months), all patients with epicardial LV leads stayed alive except for one cardiac death post-CRT 14 months and one heart transplantation post-CRT 30 months. All epicardial LV leads maintained stable performance without dislodgement/significant changes in pacing threshold/impedance. LV lead dislodgement occurred only in endocardial-LV (7/243, 2.9%). Efficacy in both groups was comparable in terms of QRS narrowing, increase in LV ejection fraction, and survival free of cardiac death, or heart-failure-related hospitalization. (4) Conclusions: Epicardial LV lead placement using VATS can be a safe and effective alternative to endocardial implantation, with comparable acute and post-discharge outcomes achieved by both approaches.
- 16 May 2022
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 9 (5) , 160
Open AccessThoracoscopic Implantation of Epicardial Left Ventricular Lead for Cardiac Resynchronization Therapy
(1) Background: Limited data exist on the safety and efficacy of epicardial left ventricular (LV) lead placement using video-assisted thoracoscopic surgery (VATS) for cardiac resynchronization therapy (CRT). (2) Methods: Acute and post-discharge outcomes of CRT were compared between patients with epicardial LV leads (Epicardial-LV group, n = 13) and those with endocardial LV leads (Endocardial-LV group, n = 243). (3) Results: Epicardial LV leads were implanted via VATS alone (n = 8) or along with mini-thoracotomy (n = 5), for failed endocardial implantation (n = 11) or recurrent lead dislodgement (n = 2). All epicardial procedures under general anesthesia with one-lung ventilation were successfully completed in 1.0 ± 0.4 h without phrenic nerve stimulation. LV pacing thresholds in the epicardial-LV (1.5 ± 1.0 V) and endocardial-LV (1.3 ± 0.8 V) were comparable (p = 0.651). All patients were discharged alive post-VATS 8.8 ± 3.9 days. During the follow-up (34.3 ± 28.6 months), all patients with epicardial LV leads stayed alive except for one cardiac death post-CRT 14 months and one heart transplantation post-CRT 30 months. All epicardial LV leads maintained stable performance without dislodgement/significant changes in pacing threshold/impedance. LV lead dislodgement occurred only in endocardial-LV (7/243, 2.9%). Efficacy in both groups was comparable in terms of QRS narrowing, increase in LV ejection fraction, and survival free of cardiac death, or heart-failure-related hospitalization. (4) Conclusions: Epicardial LV lead placement using VATS can be a safe and effective alternative to endocardial implantation, with comparable acute and post-discharge outcomes achieved by both approaches.
- Open Access
- 6 April 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (7) , 1526
Extracorporeal Membrane Oxygenation for Fulminant Myocarditis: Increase of Cardiac Enzyme and SOFA Score Is Associated with High Mortality
We aimed to evaluate the outcomes of patients with fulminant myocarditis and investigate the factors associated with mortality. This is a retrospective single-center cohort study that included adult and pediatric patients with fulminant myocarditis treated at Samsung Medical Center between September 2004 and December 2019. The primary outcome was in-hospital mortality. Among 100 patients, 71 underwent veno-arterial extracorporeal membrane oxygenation (ECMO) (ECMO group). Comorbidities were not significantly different between the ECMO and non-ECMO groups. Cardiac enzymes, creatinine, and median sequential organ failure assessment (SOFA) score at intensive care unit admission were significantly different between the groups. Twenty patients (28.7%) in the ECMO group and two (6.9%) in the non-ECMO group died in-hospital (p = 0.02). The significant risk factors of in-hospital mortality were creatine kinase MB fraction (CK-MB) and SOFA score (p = 0.009 and p = 0.001, respectively) in the ECMO group. In the receiver-operating characteristic curve analysis, the cutoffs of SOFA score and CK-MB were 12 and 94.74 ng/mL, respectively. The patients with both variables above the cutoffs showed significantly worse outcomes (p < 0.001). ECMO can be an effective treatment option for fulminant myocarditis. SOFA score and CK-MB are significant risk factors for in-hospital mortality.
- 6 April 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (7) , 1526
Open AccessExtracorporeal Membrane Oxygenation for Fulminant Myocarditis: Increase of Cardiac Enzyme and SOFA Score Is Associated with High Mortality
We aimed to evaluate the outcomes of patients with fulminant myocarditis and investigate the factors associated with mortality. This is a retrospective single-center cohort study that included adult and pediatric patients with fulminant myocarditis treated at Samsung Medical Center between September 2004 and December 2019. The primary outcome was in-hospital mortality. Among 100 patients, 71 underwent veno-arterial extracorporeal membrane oxygenation (ECMO) (ECMO group). Comorbidities were not significantly different between the ECMO and non-ECMO groups. Cardiac enzymes, creatinine, and median sequential organ failure assessment (SOFA) score at intensive care unit admission were significantly different between the groups. Twenty patients (28.7%) in the ECMO group and two (6.9%) in the non-ECMO group died in-hospital (p = 0.02). The significant risk factors of in-hospital mortality were creatine kinase MB fraction (CK-MB) and SOFA score (p = 0.009 and p = 0.001, respectively) in the ECMO group. In the receiver-operating characteristic curve analysis, the cutoffs of SOFA score and CK-MB were 12 and 94.74 ng/mL, respectively. The patients with both variables above the cutoffs showed significantly worse outcomes (p < 0.001). ECMO can be an effective treatment option for fulminant myocarditis. SOFA score and CK-MB are significant risk factors for in-hospital mortality.